GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Benevolent AI (GREY:BAIVF) » Definitions » Additional Paid-In Capital

Benevolent AI (Benevolent AI) Additional Paid-In Capital : $1,236.44 Mil(As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Benevolent AI Additional Paid-In Capital?


Benevolent AI's quarterly additional paid-in capital increased from Dec. 2022 ($1,133.37 Mil) to Jun. 2023 ($1,174.87 Mil) and increased from Jun. 2023 ($1,174.87 Mil) to Dec. 2023 ($1,236.44 Mil).

Benevolent AI's annual additional paid-in capital increased from Dec. 2021 ($280.80 Mil) to Dec. 2022 ($1,133.37 Mil) and increased from Dec. 2022 ($1,133.37 Mil) to Dec. 2023 ($1,236.44 Mil).

Benevolent AI Additional Paid-In Capital Historical Data

The historical data trend for Benevolent AI's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Benevolent AI Additional Paid-In Capital Chart

Benevolent AI Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial 220.66 274.36 280.80 1,133.37 1,236.44

Benevolent AI Quarterly Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only 280.80 1,145.58 1,133.37 1,174.87 1,236.44

Benevolent AI Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Benevolent AI Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Benevolent AI's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Benevolent AI (Benevolent AI) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Benevolent AI (GREY:BAIVF) » Definitions » Additional Paid-In Capital
Comparable Companies
Traded in Other Exchanges
BAI:Netherlands 2XA:Germany
Address
4-8 Maple Street, London, GBR, W1T 5HD
Website
https://www.benevolent.com
Benevolent AI is a clinical-stage AI-enabled drug discovery company. It delivers novel drug candidates with a higher probability of clinical success than those developed using traditional methods. The Benevolent Platform powers a growing in-house pipeline of over 20 drug programmes, spanning from target discovery to clinical studies, and it maintains commercial collaborations with pharmaceutical companies.